STAAR Surgical Q2 2025 Earnings Call Scheduled for August 6

STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

conferences earnings

07/31/2025 - 10:03 PM

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer庐 Lenses (EVO ICL鈩�) for vision correction, today announced that it will release financial results for the second quarter ended June 27, 2025, on Wednesday, August 6, 2025 after the market close. The Company will also host an earnings call and webcast at 4:30 p.m. ET to discuss its financial results and business progress.

Event: STAAR Surgical 2Q 2025 Financial Results Webcast
Date: Wednesday, August 6, 2025
Time: 4:30 p.m. ET
Location:

The live webcast, including an option to pre-register, can be accessed at the preceding link or the 鈥淚nvestors鈥� section of the STAAR website at . A webcast replay will be available at the same link for at least 90 days.

About STAAR Surgical

STAAR Surgical (NASDAQ: STAA) is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic surgery, and for 30 years, STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer庐 Lenses (ICLs), using its proprietary biocompatible Collamer material. STAAR ICLs are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye鈥檚 natural crystalline lens. Its EVO ICL鈩� product line provides visual freedom through a quick, minimally invasive procedure. STAAR has sold more than 3 million ICLs in over 75 countries. Headquartered in Lake Forest, California, the company operates research, development, manufacturing, and packaging facilities in California and Switzerland. For more information about ICL, visit . To learn more about STAAR, visit .

We intend to use our website as a means of disclosing material non-public information about the Company and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included on our website in the 鈥業nvestor Relations鈥� sections at investors.staar.com. Accordingly, investors should monitor such portion of our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the News & Alerts section at .